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ABSTRACT 
H i g h l y p u r i f i e d s e c r e t o r y v e s i c l e s from a d r e n a l m e d u l l a , i s o l a t e d by 
d i f f e r e n t i a l and d e n s i t y g r a d i e n t c e n t r i f u g a t i o n u s i n g i s o t o n i c g r a -
d i e n t m a t e r i a l (Percoll™), c o n t a i n a c e t y l c h o l i n e s t e r a s e . The enzyme 
was l a t e n t i n i s o l a t e d s e c r e t o r y v e s i c l e s i . e . a c e t y l c h o l i n e s t e r a s e 
was i n a c c e s s i b l e t o added S u b s t r a t e . The enzyme a c t i v i t y became p a t e n t 
a f t e r a d d i t i o n of d e t e r g e n t or i n h y p o t o n i c media. Hypotonie treatment 
or s p e c i f i c l y s i s of the v e s i c l e s w i t h Mg2+/ATP i n the presence of a 
permeant a n i o n r e s u l t e d i n the r e l e a s e of s o l u b l e a c e t y l c h o l i n e s t e r a s e 
from the v e s i c u l a r c o n t e n t . Membrane-bound enzyme sedimented w i t h the 
membranes. B i n d i n g of a-bungarotoxin c o u l d o n l y be observed when se-
c r e t o r y v e s i c l e s were l y z e d . 
I t i s c o n c l u d e d , t h a t the a c e t y l c h o l i n e r e c e p t o r as w e l l as the mem-
brane-bound form a a c e t y l c h o l i n e s t e r a s e are l o c a l i z e d on the i n n e r 
s u r f a c e of the s e c r e t o r y v e s i c l e membrane, which becomes the o u t e r 
s u r f a c e of the c e l l membrane d u r i n g e x o e y t o s i s . C o n c o m i t a n t l y the so-
l u b l e form of a c e t y l c h o l i n e s t e r a s e p r e s e n t w i t h i n s e c r e t o r y v e s i c l e s 
i s r e l e a s e d i n t o the e x t r a c e l l u l a r f l u i d . 
KEYWORDS 
A c e t y l c h o l i n e s t e r a s e ; a c e t y l c h o l i n e r e c e p t o r ; s e c r e t o r y v e s i c l e s ; 
a d r e n a l m e d u l l a . 
INTRODUCTION 
Duri n g e x o e y t o s i s s e c r e t o r y v e s i c l e c o n t e n t s are r e l e a s e d i n t o the ex-
t r a c e l l u l a r f l u i d and t h e i r l i m i t i n g membranes are i n c o r p o r a t e d i n t o 
the c e l l membrane. In t h i s way the i n s i d e of the s e c r e t o r y v e s i c l e 
membrane becomes the o u t s i d e of the c e l l membrane. The e x i s t e n c e of 
c e l l membrane components on the i n n e r s u r f a c e of s e c r e t o r y v e s i c l e 
membranes would be c o n s i s t e n t w i t h a b i o g e n e t i c r e l a t i o n s h i p between 
the s e c r e t o r y v e s i c l e and the c e l l membrane. In t h i s r e p o r t we des-
c r i b e e v i d e n c e f o r the l o c a t i o n of such c e l l membrane components, the 
a c e t y l c h o l i n e s t e r a s e and the a c e t y l c h o l i n e r e c e p t o r of the c h r o m a f f i n 
c e l l , w i t h i n s e c r e t o r y v e s i c l e s . 
RESULTS AND DISCUSSION 
S e c r e t o r y v e s i c l e s from a d r e n a l m e d u l l a , i s o l a t e d by d i f f e r e n t i a l cen-
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t r i f u g a t i o n , were f u r t h e r p u r i f i e d on a c o n t i n u o u s s e i f g e n e r a t i n g 
Percoll™ g r a d i e n t . An o s m o l a l i t y of 420 mosmol/kg was m a i n t a i n e d 
throughout the procedure. In t h i s way h i g h l y p u r i f i e d s e c r e t o r y ve-
s i c l e s wereobtained t h a t l e a k e d i n t r a v e s i c u l a r a d r e n a l i n o n l y s l o w l y 
( G r a t z l , K r i e g e r - B r a u e r and E k e r d t , 1981). 
The v e s i c l e s were found t o c o n t a i n a c e t y l c h o l i n e s t e r a s e w i t h a s p e c i -
f i c a c t i v i t y o f about 14 nmoles S u b s t r a t e h y d r o l y z e d per minand mg 
p r o t e i n ( = t o t a l a c t i v i t y , determined i n the presence of 0.2% T r i t o n 
X 100). With no d e t e r g e n t added and i n media of an o s m o l a l i t y of 420 
mosmol/kg enzyme a c t i v i t y amounted o n l y t o about 4% of the t o t a l ac-
t i v i t y ( F i g . 1 ). 
£ 0 J i . . - i r -
0 100 200 300 400 
O s m o l a l i t y ( m o s m o l / k g ) 
F i g . 1 . Latency of a c e t y l c h o l i n e s t e r a s e of i s o l a -
t e d s e c r e t o r y v e s i c l e s . The v e s i c l e s were 
i n c u b a t e d f o r 5 min a t room temperature 
i n sucrose media of d i f f e r e n t o s m o l a l i t i e s . 
The enzyme a c t i v i t y was determined w i t h o u t 
d e t e r g e n t added or w i t h 0.2% T r i t o n X 100 
p r e s e n t (100%). 
R e d u ction of the o s m o l a l i t y r e s u l t s i n an i n c r e a s e of the enzyme a c t i -
v i t y . Below 200 mosmol/kg, an o s m o l a l i t y a t which the v e s i c l e s have 
d e p l e t e d a l l t h e i r i n t r a v e s i c u l a r a d r e n a l i n ( G r a t z l , 1 9 8 0 ) , no f u r t h e r 
i n c r e a s e i n enzyme a c t i v i t y c o u l d be d e t e c t e d ( F i g . 1 ) . D uring hypoto-
n i c treatment (200 mosmol/kg) of s e c r e t o r y v e s i c l e s about one t h i r d 
of the t o t a l a c e t y l c h o l i n e s t e r a s e was r e l e a s e d i n t o the s u p e r n a t a n t 
(Table 1 ) , w h i l e the re m a i n i n g a c t i v i t y sedimented w i t h the membranes. 
O b v i o u s l y a membrane-bound p o o l o f a c e t y l c h o l i n e s t e r a s e e x i s t s w i t h i n 
s e c r e t o r y v e s i c l e s a l o n g w i t h the s o l u b l e pool which c o u l d a l s o be r e -
l e a s e d from the v e s i c l e s by 2 mM Mg 2 +/ATP i n the presence of K C l , but 
not i n the presence of suc r o s e (Table 1 ) . L y s i s of s e c r e t o r y v e s i c l e s 
as a consequence of an ATP d r i v e n p r o t o n pump i n the presence of a 
permeant a n i o n has been d e s c r i b e d e a r l i e r (Casey and Co l l e a g u e s , 1 9 7 6 ) . 
R e c e n t l y we have d e t e c t e d , t h a t the membrane-bound form of a c e t y l c h o -
l i n e s t e r a s e can be d i s t i n g u i s h e d from the s o l u b l e enzyme by i t s e l e c -
t r o p h o r e t i c m o b i l i t y ( G r a t z l , K r i e g e r - B r a u e r and E k e r d t , 1981). 
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Table 1 RELEASE OF ACETYLCHOLINESTERASE FROM 
ISOLATED SECRETORY VESICLES 
Medium O s m o l a l i t y A c e t y l c h o l i n e s t e r a s e 
(mosmol/kg) i n Supernatant (%) 
Sucrose 420 T71 
KCl 4 20 4.7 
Sucrose, Mg /ATP 4 20 2.6 
K C l , Mg 2 +/ATP 420 23.6 
Sucrose 200 32.6 
I s o l a t e d s e c r e t o r y v e s i c l e s were i n c u b a t e d f o r 30 
min a t 37°C i n 20 mM Mops, pH 7.0, 1 mM EGTA and 
sucrose or KCl to o b t a i n the f i n a l o s m o l a l i t y as 
i n d i c a t e d . The c o n c e n t r a t i o n of Mg2 + and ATP was 
2 mM. The m i x t u r e s were c e n t r i f u g e d f o r 10 min a t 
130000 g a v i n a Beckman Airfuge™ and the enzyme 
a c t i v i t y was determined i n the s u p e r n a t a n t . T o t a l 
enzyme a c t i v i t y (=100%) was determined i n the p r e -
sence of 0.2% T r i t o n X 100. 
The experiments d e s c r i b e d so f a r show, t h a t s e c r e t o r y v e s i c l e s from 
a d r e n a l medulla c o n t a i n two types of a c e t y l c h o l i n e s t e r a s e , both se-
q u e s t e r e d by the v e s i c u l a r membrane from the s u r r o u n d i n g medium. One 
type i s membrane-bound, but f a c e s the i n t r a v e s i c u l a r space, the o t h e r 
type i s p a r t of the v e s i c u l a r c o n t e n t . In the f o l l o w i n g we p r o v i d e 
e v i d e n c e , t h a t a l s o the a c e t y l c h o l i n e r e c e p t o r i s arranged i n an aSym-
m e t r i e way i n the s e c r e t o r y v e s i c l e membrane, namely on the i n n e r s u r -
f a c e . a-bungarotoxin d i d not b i n d t o i n t a c t s e c r e t o r y v e s i c l e s . How-
ev e r , when the v e s i c l e s were l y z e d i n the presence of the venom, spe-





"~ < * - B u n g a r o t o x i n ( n M ) 
F i g . 2 B i n d i n g of [ H] a-bung a r o t o x i n t o 
s e c r e t o r y v e s i c l e s . 
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I s o l a t e d s e c r e t o r y v e s i c l e s were l y z e d h y p o t o n i -
c a l l y ( f i n a l o s m o l a l i t y 170 mosmol/kg) i n the p r e -
sence of d i f f e r e n t c o n c e n t r a t i o n s of [ 3H] a-bunga-
r o t o x i n o r [^H] a-bungarotoxin p l u s a c o n s t a n t 
amount of unlabelled a -bungarotoxin (5x10~^M). I n -
c u b a t i o n was c o n t i n u e d f o r 45 min a t room tempera-
t u r e . Membranes were s e p a r a t e d from the medium i n 
a sucrose Step g r a d i e n t . The r a d i o a c t i v i t y of the 
m a t e r i a l r e c o v e r e d from the g r a d i e n t was d e t e r -
mined by l i q u i d s c i n t i l l a t i o n c o u n t i n g . S p e c i f i c 
b i n d i n g was o b t a i n e d from the d i f f e r e n c e between 
the amount of [ 3H] a-bungarotoxin bound i n the 
absence and the presence of u n l a b e l l e d a-bungaro-
t o x i n . 
At the c o n c e n t r a t i o n of 40 nM s p e c i f i c b i n d i n g of a-bungarotoxin was 
a p p r o x i m a t e l y s a t u r a t e d and the number of b i n d i n g S i t e s was 33 fmole/ 
mg membrane p r o t e i n . S a t u r a t i o n of a - b u n g a r o t o x i n b i n d i n g S i t e s of 
c e l l membranes i s o l a t e d from a d r e n a l m e d u l l a was observed a t 4 nM and 
the number of S i t e s was 190 fmole/mg membrane p r o t e i n (Wilson and 
K i r s h n e r , 1 9 7 7 ) . 
Concerning the d i s t r i b u t i o n and the t r a n s p o r t of a c e t y l c h o l i n e s t e r a s e 
and a c e t y l c h o l i n e r e c e p t o r , i n t e r e s t i n g p a r a l l e l o b s e r v a t i o n s have 
been made w i t h c h r o m a f f i n c e l l s as w e l l as w i t h myoblasts. Both types 
of c e l l s i n c u l t u r e r e l e a s e s o l u b l e a c e t y l c h o l i n e s t e r a s e i n t o the me-
dium (Rotundo and Famborough,1980a, Rotundo and Famborough,1980, 
Mizobe and L i v e t t , 1 9 8 0 ) . In m y o b l a s t s , newly formed a c e t y l c h o l i n e s -
t e r a s e and a c e t y l c h o l i n e r e c e p t o r s were found l o c a l i z e d w i t h i n i n t r a -
c e l l u l a r o r g a n e l l e s . A l t h o u g h a c e t y l c h o l i n e s t e r a s e i s s e c r e t e d i n a 
Ca2+-dependent manner by s t i m u l a t e d a d r e n a l g l a n d s , the mechanism of 
t h i s p r o c e s s remained obscure (Chubb and Smith,1975a,Chubb and Smith, 
1975b,Somogyi and C o l l e a g u s , 1 9 7 5 ) . S i n c e i t has been shown now, t h a t 
a c e t y l c h o l i n e s t e r a s e (as w e l l as a c e t y l c h o l i n e r e c e p t o r ) i s p r e s e n t 
w i t h i n a d r e n a l m e d u l l a r y s e c r e t o r y v e s i c l e s , an e x o c y t o t i c pathway i s 
l i k e l y t o o c c u r . 
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P o l y p e p t i d e s 18 and 38 KD 435 
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P u r p l e membrane 183 
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R e c e p t o r b i n d i n g 487 
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R e c y c l i n g 447 
R e j e c t i o n 691 
R e l a t i o n s t r u c t u r e f u n c t i o n 377 
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S c h i s t o s o m u l a 179 
S c r e e n i n g p r o c e d u r e s 631, 637 
S e c r e t i n 509, 513 
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S e l e c t i o n 627 
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965 
S u b s e t s 713 
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S u b t y p e s 743 
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S u r f a c e g l y c o p r o t e i n s 63 
SV 40 159 
S y n a p t i c p l a s m a membrane 151 
Sy n a p t o s o m e s 535 
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T c e l l s u b s e t s 667 
T c e l l s 6 83, 705, 729 
T c e l l s c y t o t o x i c 663 
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T u n i c a m y c i n 67 
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